Today, researchers have announced a major breakthrough in the treatment of schistosomiasis, a neglected tropical disease that affects more than 200 million people worldwide. For the first time ever, a single dose of the new drug, known as Prazimin, was found to be even more effective than the current standard of treatment, which requires multiple doses over the course of months. In addition, the effects of Prazimin were found to last for up to a year, making it a potential game-changer in the fight against schistosomiasis.

Read Full Article Here

source: Phys.org